Abstract
Some neuro-sensorial troubles of the inner ear have been shown to be possibly related to metabolic disorders, among them hyperlipidemia (Spencer 1973; Martin and Oudot 1977). Except Lidocaine intravenously, no drug has shown real effectiveness in a controlled double-blind placebo trial to treat tinnitus aurium. In a previous pilot study (Torossian and Laredo 1986), fenofibrate, Lipanthyl, a well-known hypolipidemic compound (Blane et al. 1986), has already demonstrated an activity against not only-hyperlipidemia but also against some neuro-sensorial troubles of the inner ear. The aim of the present trial was to evaluate more precisely the effectiveness of fenofibrate on some cochleo-vestibular problems, notably tinnitus and hypacusia, in hyperlipidemic patients.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Arntz HR, Heitz J, Schäfer JH, Oeff M, Zingler G (1985) Influence of fenofibrate on pathological blood rheology in type II hyperlipoproteinemia. Abstract 457 of the 7th Int Symp Atherosclerosis, Melbourne (Australia), Oct 1985, Proc Poster Commun PJ Nestel
Blane GF, Bogaievsky Y, Bonnefous F (1986) Fenofibrate: influence on circulating lipids and side-effects in medium and long-term clinical use. In: Sears R (ed) Pharmacological control of hyperlipidaemia. Prous, Barcelona, pp 187–216
Duckert LG, Rees TS (1983) Treatment of tinnitus with intravenous lidocaine: a double-blind randomized trial. Otolaryngol Head Neck Surg 91:550–555
Martin FW, Colman BH (1980) Tinnitus: a double-blind cross-over controlled trial to evaluate the use of lignocaine. Clin Otolaryngol 5:3–11
Martin H, Oudot J (1977) Dysmétabolisme lipidique et surdites d’oreille interne. J Fr Oto-Rhino-Laryng 26:725–728
Perutz MF, Poyart C (1983) Bezafibrate lowers oxygen affinity of haemoglobin. Lancet 2:881 – 882
Spencer JT (1973) Hyperlipoproteinemias in the etiology of inner ear disease. Laryngoscope 83: 639–678
Torossian F, Laredo C (1986) Cochleovestibular disorders and hyperlipidemia. A controlled trial with fenofibrate. Monogr Atherosclerosis 14:222–229
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1987 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Bogaievsky, Y., Torossian, F., Jost, G., Bonnefous, F. (1987). Clinical Effect of Lipanthyl on Tinnitus Aurium and Other Symptoms Related to Inner Ear Disorders. In: Paoletti, R., Kritchevsky, D., Holmes, W.L. (eds) Drugs Affecting Lipid Metabolism. Proceedings in Life Sciences. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-71702-4_64
Download citation
DOI: https://doi.org/10.1007/978-3-642-71702-4_64
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-71704-8
Online ISBN: 978-3-642-71702-4
eBook Packages: Springer Book Archive